Tatva Chintan Pharma Chem Limited IPO
Tatva Chintan Pharma Chem Limited was a mainboard IPO in the Specialty Chemicals sector, offered at ₹1,073–₹1,083 per share to raise ₹500 crore. The issue was subscribed 180.36× overall (QIBs 185.23×, NIIs 512.22×, retail 35.35×). It listed on 29 Jul 2021 at ₹2,112 and closed its first day at ₹2,312, a listing gain of +113.5% versus the ₹1,083 issue price. It now trades around ₹1,644 (+51.8% versus the issue price).
Frequently asked questions
- How many times was the Tatva Chintan Pharma Chem Limited IPO subscribed?
- The Tatva Chintan Pharma Chem Limited IPO was subscribed 180.36× overall — 185.23× in the QIB category, 512.22× among non-institutional investors, 35.35× in retail.
- What were the Tatva Chintan Pharma Chem Limited IPO listing gains?
- Tatva Chintan Pharma Chem Limited listed on 29 Jul 2021 at ₹2,112, closing its first day at ₹2,312 — a listing gain of +113.5% versus the ₹1,083 issue price.
- What were the retail allotment odds for the Tatva Chintan Pharma Chem Limited IPO?
- Retail was subscribed 35.35×, so a single-lot application had roughly a 2.8% chance of allotment (about 1 in 35), and allotment was finalised on 23 Jul 2021.
- What was the price band and lot size of the Tatva Chintan Pharma Chem Limited IPO?
- The price band was ₹1,073–₹1,083 per share, with a minimum lot of 13 shares (₹14,079 at the upper band).
- Who were the registrar and lead manager for the Tatva Chintan Pharma Chem Limited IPO?
- Link Intime India Private Limited was the registrar, and ICICI Securities was the book-running lead manager.